A prospective, multicenter, noninterventional study of Optive Plus® in the treatment of patients with dry eye: the prolipid study

por Kaercher T, Thelen U, Brief G, Morgan-Warren RJ, Leaback R
Publicado 2014

Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice

por Pillunat LE, Eschstruth P, Häsemeyer S, Thelen U, Foja C, Leaback R, Pfennigsdorf S
Publicado 2016

Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension

por Laube T, Cooper H, Schnober D, Spraul C, Thelen U, Froböse M, Eschstruth P, Mäder B, von Kistowski G, Ramez O, Pfennigsdorf S
Publicado 2012